{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:22:38Z","timestamp":1790889758382,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.oret.2025.03.022","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T03:08:53Z","timestamp":1743476933000},"page":"928-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endophthalmitis Incidence after Intravitreal Injection of Anti-VEGF Agents with Povidone-Iodine versus Aqueous Chlorhexidine Antisepsis"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8702-8043","authenticated-orcid":false,"given":"Brandon","family":"Bates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6109-257X","authenticated-orcid":false,"given":"Caroline","family":"Rosanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-4410","authenticated-orcid":false,"given":"Jared","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.03.022_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000502387","article-title":"Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence","volume":"243","author":"Wong","year":"2020","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2025.03.022_bib2","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.oret.2025.03.022_bib3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.022_bib4","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0161-6420(01)00754-0","article-title":"Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration","volume":"108","author":"Brody","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.022_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamaophthalmol.2016.2213","article-title":"Association between diabetes-related eye complications and symptoms of anxiety and depression","volume":"134","author":"Rees","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.022_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/2474126419893829","article-title":"American Society of Retina Specialists Clinical Practice Guidelines on the management of nonproliferative and proliferative diabetic retinopathy without diabetic macular edema","volume":"4","author":"Yonekawa","year":"2020","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.03.022_bib7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bjophthalmol-2020-317434","article-title":"Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence","volume":"105","author":"Daien","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.022_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archopht.1984.01040030584025","article-title":"Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva","volume":"102","author":"Apt","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.022_bib9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.022_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.oret.2020.11.008","article-title":"Aqueous chlorhexidine compared with povidone-iodine as ocular antisepsis before intravitreal injection: a randomized clinical trial","volume":"5","author":"Ali","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.022_bib11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/j.jcrs.0000000000001436","article-title":"In vivo assessment of antimicrobial activity and toxicity of repeated 1% povidone-iodine applications vs a single 5% povidone-iodine application","volume":"50","author":"Teren","year":"2024","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.oret.2025.03.022_bib12","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1097\/IAE.0000000000001800","article-title":"Pain and antisepsis after ocular administration of povidone-iodine versus chlorhexidine","volume":"38","author":"Oakley","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.03.022_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/15569527.2017.1291665","article-title":"Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections","volume":"36","author":"Saedon","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.oret.2025.03.022_bib14","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.ophtha.2016.08.022","article-title":"Aqueous chlorhexidine for intravitreal injection antisepsis: a case series and review of the literature","volume":"123","author":"Merani","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.022_bib15","first-page":"664","article-title":"Chlorhexidine gluconate 0.02% as adjunct to primary treatment for corneal bacterial ulcers","volume":"11","author":"Geffen","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.oret.2025.03.022_bib16","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1111\/aos.12981","article-title":"Aqueous chlorhexidine (0.1%) is an effective alternative to povidone-iodine for intravitreal injection prophylaxis","volume":"94","author":"Oakley","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.022_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.oret.2023.12.004","article-title":"Endophthalmitis after anti-VEGF intravitreal injections with aqueous chlorhexidine versus povidone-iodine as ocular antiseptics","volume":"8","author":"Ton","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.022_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jcjo.2024.01.012","article-title":"Rates of endophthalmitis before and after transition from povidone-iodine to aqueous chlorhexidine asepsis for intravitreal injection","volume":"59","author":"Stephenson","year":"2024","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.022_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.oret.2023.08.007","article-title":"Comparison of endophthalmitis rates after alcohol-based chlorhexidine and povidone-iodine antisepsis for intravitreal injections","volume":"8","author":"Mishra","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.022_bib20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/eye.2015.3","article-title":"The Royal College of Ophthalmologistsologists\u2019 National Ophthalmology Database2024.01.012ravitreal injection. eal injection. njection. -iodine","volume":"29","author":"Day","year":"2015","journal-title":"Eye (Lond Engl)"},{"key":"10.1016\/j.oret.2025.03.022_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ajic.2010.06.022","article-title":"Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens","volume":"38","author":"Anderson","year":"2010","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.oret.2025.03.022_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0310057X0803600404","article-title":"Chlorhexidine--pharmacology and clinical applications","volume":"36","author":"Lim","year":"2008","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.oret.2025.03.022_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40942-015-0010-y","article-title":"Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review","volume":"1","author":"Merani","year":"2015","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2025.03.022_bib24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jcrs.2013.02.039","article-title":"Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery","volume":"39","author":"Li","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.oret.2025.03.022_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jcrs.2007.08.035","article-title":"Prospective comparative evaluation of povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery","volume":"34","author":"Ta","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.oret.2025.03.022_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/jcm.15.4.635-639.1982","article-title":"Increased bactericidal activity of dilute preparations of povidone-iodine solutions","volume":"15","author":"Berkelman","year":"1982","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.oret.2025.03.022_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.oret.2018.09.013","article-title":"Predictors of endophthalmitis after intravitreal injection: a multivariable analysis based on injection protocol and povidone iodine strength","volume":"3","author":"Stem","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.03.022_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.1989.03420040091021","article-title":"Corneal damage due to eye contact with chlorhexidine gluconate","volume":"261","author":"Tabor","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2025.03.022_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00003226-199010000-00014","article-title":"Hibiclens keratopathy. A clinicopathologic case report","volume":"9","author":"Varley","year":"1990","journal-title":"Cornea"},{"key":"10.1016\/j.oret.2025.03.022_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/ICO.0b013e318218237e","article-title":"Ocular surface reconstruction after exposure to high concentrations of antiseptic solutions","volume":"31","author":"Shigeyasu","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.oret.2025.03.022_bib31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/j.jcrs.0000000000000599","article-title":"In vitro study examining the effectiveness of antiseptic prophylaxis for antibiotic-resistant bacterial endophthalmitis","volume":"47","author":"O\u2019Rourke","year":"2021","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.oret.2025.03.022_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0420.2005.00414.x","article-title":"Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting","volume":"83","author":"Barkana","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.oret.2025.03.022_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2018.11.023","article-title":"The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab","volume":"199","author":"Storey","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.022_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/24741264231159011","article-title":"Reduced incidence of intravitreal injection-related endophthalmitis with prefilled syringes","volume":"7","author":"Feng","year":"2023","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.03.022_bib35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/24741264231191339","article-title":"Impact of prefilled syringes and masking on postintravitreal injection endophthalmitis","volume":"7","author":"Louis","year":"2023","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.03.022_bib36","author":"Corporation"},{"key":"10.1016\/j.oret.2025.03.022_bib37","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.ophtha.2021.05.010","article-title":"The influence of universal face mask use on endophthalmitis risk after intravitreal anti-vascular endothelial growth factor injections","volume":"128","author":"Patel","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.022_bib38","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1111\/aos.14945","article-title":"Mask use by patients in the context of COVID-19 can increase the risk of postinjection endophthalmitis","volume":"100","author":"Blom","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.03.022_bib39","article-title":"Face masking and risk of endophthalmitis after intravitreal injection: a network meta-analysis of 2.6 million injections","author":"Tao","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.03.022_bib40","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3928\/23258160-20151027-07","article-title":"Effect of a strict \u201cno-talking\u201d policy during intravitreal injection on post-injection endophthalmitis","volume":"46","author":"Garg","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:30:01Z","timestamp":1759343401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2468653025001435"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.022","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endophthalmitis Incidence after Intravitreal Injection of Anti-VEGF Agents with Povidone-Iodine versus Aqueous Chlorhexidine Antisepsis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}